Maharashtra to provide free vaccination to all citizens above 18 years

Govt. to float global tender to procure best vaccine at best possible price, says Minister

Published - April 25, 2021 04:46 pm IST - Pune

Long queues outside BKC Jumbo vaccination centre in Mumbai

Long queues outside BKC Jumbo vaccination centre in Mumbai

The Uddhav Thackeray government is in favour of providing free vaccination for its citizens above 18 years in the third phase of vaccination drive, said Cabinet Minister Nawab Malik on Sunday.

Mr. Malik said the “Maha Vikas Aghadi government” will float a global tender to procure the “best vaccine at the best possible price” to fight the scourge. He said for two doses per person, the State government would need to purchase 14-15 crore vials for the third phase of the drive.

“The Centre had earlier announced vaccination for all citizens above 18 years with the caveat that the expenditure for the inoculation for citizens between 18-45 years will have to borne by the State governments. In the last Cabinet meeting, we discussed this issue and it was unanimously decided that the State would provide for the vaccination of all citizens in the 18-45 age group,” he said.

Following the Centre’s announcement, Mr. Malik said the Serum Institute of India (SII) had given its pricing for per dose of its ‘Covishield’ as ₹150 for the Central government, ₹400 for State governments and ₹600 for private hospitals while the Bharat Biotech (which rolls out ‘Covaxin’) had put out its price as ₹150, ₹600 and ₹1,200 respectively .

“Now that the prices of these two indigenous companies are out, Deputy Chief Minister Ajit Pawar, who is also the Finance Minister has said the government would float a global tender to get the best vaccine at the most competitive price,” said Mr. Malik.

Also read: Centre contradicts Serum Institute of India on Covishield pricing, to purchase at ₹150 per dose

Facing criticism over its pricing of the Covishield, the SII on Saturday had responded by noting the “inaccurate comparisons between the global prices of the vaccine with that in India” while stating that Covishield remained “the most affordable vaccine available in the market today”.

“The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing. The initial supply price of Covishield for all government immunisation programme, including India, has been the lowest.”

It had further clarified that only a limited portion of the SII’s volume would be sold to private hospitals and that the price was still lower than a lot of other medical treatment and essentials required to treat COVID-19 and other life-threatening diseases.

With Maharashtra facing a high demand for medical oxygen in the wake of ever-rising cases, 14 plants for producing the life-saving gas from the atmospheric air would be set-up in the Mumbai Metropolitan Region (MMR), said Minister Eknath Shinde.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.